Guardant Health Inc. (5GH)
Munich
Real-time Data
06:00 AM
Day's Range
141.3652 wk Range
46.91Overview - 5GH - Guardant Health Inc.
Key Statistics
Valuation
Enterprise Value
1.33B
P/E (Trailing)
‪-44.11‬
PEG Ratio
‪-3.52‬
Price / Book
‪-87.31‬
EV / EBITDA
‪-3.56‬
Profitability
Gross Margin
‪65.38%‬
Profit Margin
‪64.46%‬
Operating Margin
‪-42.12%‬
Return on Assets
‪-20.67%‬
Return on Equity
‪419.18%‬
Ownership
Shares Outstanding
133.61M
Price stats
50-Day Avg
‪135.25‬
200-Day Avg
‪99.29‬
Peers - 5GH - Guardant Health Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on Munich.
- 5GHMunichGuardant Health Inc.+61.55%52-week change-42.58P/E (Trailing)‪64.46%‬Profit Margin
- 45EMunichNATERA INC (Common Stock) – ticker 45E+55.09%52-week change-125.99P/E (Trailing)‪-9.04%‬Profit Margin
- 1HMMunichAdaptive Biotechnologies Corporation+50.16%52-week change-56.23P/E (Trailing)‪-20.72%‬Profit Margin
- 0MEMunichTwist Bioscience Corporation+80.48%52-week change-93.58P/E (Trailing)‪50.72%‬Profit Margin
- 1K9MunichCareDx Inc.+74.78%52-week change-108.50P/E (Trailing)‪67.55%‬Profit Margin
- 04XMunichPersonalis Inc.+72.42%52-week change-16.38P/E (Trailing)‪22.65%‬Profit Margin
- NG9MunichNeoGenomics Inc.+59.90%52-week change-16.92P/E (Trailing)‪43.21%‬Profit Margin
Profile Summary - 5GH - Guardant Health Inc.
About
Guardant Health Inc. is a precision oncology company that develops and provides blood and tissue-based tests, along with vast data sets and advanced analytics, to support cancer treatment, monitoring, and early detection. Its core offerings include the Guardant360 family of liquid biopsy tests, such as Guardant360 CDx…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
